Sat, Aug 23, 2014, 12:30 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

NanoLogix Inc. Message Board

  • jasonadamaz jasonadamaz Jan 18, 2011 12:37 AM Flag

    4th Conference exhibit? May/ASM/New Orleans?

    Wow is this another conference exhibit?
    Did I miss this announcement or press release. Sorry if this info is already out there.

    http://gm.asm.org/

    May 20th-24th ASM 2011 in New Orleans!!!???
    I did not know we were going to another conference in May? All you southerners should head down to New Orleans!!

    http://gm.asm.org/index.php/exhibition/exhibit-hall-floor-plan

    Check out where the booth is-right next to the food court and laptop center - nice location. Even better is the list of other exhibitors. Good news that the big boys will be scoping out Nanologix. Siemens, BD, BioRad, BioMerieux!

    Booth 445
    http://gm.asm.org/images/stories/205-1105-004__ASM_2011_Halls_A-C_Sales_-_01-14-11.pdf


    We already know about Dubai Jan 24
    And we know about the press release for ASM Biodefense in February in Wash DC and Food Safety Summit in April in Wash DC.

    We know about this one:

    "CEO Barnhizer plans to attend Arab Health 2011, the world's second-largest medical exhibition, in Dubai January 24 - 27, where AMGKWT will be an exhibitor. For information on Arab Health 2011: http://www.arabhealthonline.com/Event-Info/About-Arab-Health/"

    And we know about these two:

    "NanoLogix will be an exhibitor at the 2011 ASM Biodefense and Emerging Diseases Research Meeting held in The Omni Shoreham Hotel, Washington, D.C., on February 6th - 9th, 2011. Booth Number: 20. Floor Plan.
    NanoLogix will also exhibit at the 2011 Food Safety Summit Conference and Expo presented in theWalter E. Washington Convention Center, Washington, D.C., on April 19th - 21st, 2011. Booth Number: 502. Floor Plan."

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • FUBAR, I want it on record that I never said your post bring nothing to the table on this board. You bring stupidity, ignorance and a general annoyance to everyone who reads your post (luckily that number is dwindling) on a daily basis. >>

      Any you bring what ?

    • Here is the man who tells the board I bring nothing, well his post was a bunch of nothing ! It's Jan 25 and where is my EPA news ??

      http://messages.finance.yahoo.com/Business_%26_Finance/Investments/Stocks_%28A_to_Z%29/Stocks_N/threadview?bn=73175&tid=37531&mid=37531

    • Lockshed

      Great post! I would just like to add that their patents state that the kits can be used for antibiotic sensitivity. I would have to say it make no sense to me why they would use the kits to identify the bacteria and then use a petri dish to identify the proper antibiotic.
      Its like taking your car to the store and parking half way there and walking the rest of the way.>>

      Abig says I bring nothing to the table and then looking at this post it's amazing his reasoning abilities ! It's makes no sense to you why they would use the kits to identify the bacteria only , well someone needs to read those news updates on GBS because thats what it reads they are doing, please point to one News update that states other while ! Parking half way and walking the rest of the way it appears so far ! Please don't try to post your crap to get people thinking just because it makes sense thats the way it going be !

      Also, your long drawn out explanation on why EPA news was going happen back on Jan 15, made sense to you yet did it happen ?

    • i think the company has alredy issued shares, esp back when the stock price was higher, anyway i think they got a good price for them especially if you consider how low the price is now, its a good thing the company had the opportunity to issue shares at a premium im sure their strapped with cash now

    • Once TMC proves that NNLX's products will do what they say it will do, maybe Bret will get an offer he can't refuse from one of the "BIG" boys that are going to be at the show,
      No use buying a car if you don't know yet if it will run.

      Coal

    • <<Hey seriously, didn't the company say not too long ago that they had enough cash on hand for 3 years of operations. Why no link for that in your slanted and biased post?>>

      Do you mean to imply that only my posts are slanted and biased? Yes, last May the company stated it had raised enough $$ to date in 2010 to provide "basic operating capital for the company for the next three years."

      Regardless, I am expecting the company will print more shares to raise cash by the end of 2011. So I guess the short explanation is that I don't believe the claim $1.4mil is sufficient to cover 3 years worth of "basic operating costs", however Barnhizer defines that term, means the company won't raise more cash before the end of three years.

      Furthermore, this company has made a number of projections that didn't materialize as expected. So if you think there will be no more dilution for three years because of that statement, I don't think you are doing adequate DD or fully appreciate all the expenditures the company appears to be taking on while still not showing it has ramped-up sales of its products.

      <<So if I did have a private chat with Barnhizer and he did confirm that the quick test kits do address antiobiotic sensitivities, would he not have pretty much been echoing with Dr. Faro said a couple months ago in this excerpt?>>

      Is the confirmation from Barnhizer in a private chat a hypothetical or did it happen?

      As for Dr. Faro's statement, no, I don't think that can be read as an indication the current TMC trial is also set up to test whether NNLX technology can determine which antibiotics to use.

      <<You might say Dr. Faro was simply saying the test can detect GBS rapidly. But so can PCR right? So why the NanoLogix quick test kits? I believe because they address antibiotic sensitity. Kind of an all in one process, where PCR falls short. PCR, you go the broad spectrum antibiotic route.>>

      What is the TMC trial seeking to compare? Here's a quote from one of the PRs:

      "Initial studies are now underway to compare the Nanologix method with the traditional culture technique. We at the University of Texas Health Science Center in Houston are excited to be a part of these early studies. A clinical trial is underway in which 300 patients will be enrolled, and the traditional method of culturing and identifying GBS will be compared with the Nanologix method."

      Certainly the objectives of the trial can include more than just comparing the speed of detection between NNLX method and traditional culture method. However, that's all that is mentioned and I have not seen anything from a reliable source that states the trial will also be used to measure the ability of NNLX technology to determine antibiotic sensitivity. Again, if I'm wrong about this, great, especially if the trial results confirm any company claims to this end.

      And just to better ensure you don't take off down another rabbit hole, this was my original post that you claim I am wrong about:

      "<<NNLX can find The proper antibiotic on their products.>>

      Has this been validated yet outside the company's laboratory? Is identifying the proper antibiotic w/NNLX technology part of the ongoing TMC trial? I believe the answer to both is no.

      Translating a patent claim into an appropriately approved and superior commercial tool should not be viewed as a sure thing nor expected to be quickly accomplished."

      http://messages.finance.yahoo.com/Business_%26_Finance/Investments/Stocks_%28A_to_Z%29/Stocks_N/threadview?bn=73175&tid=37827&mid=37921

      <<If successful, (which I think they will be), the study at TMC is a gateway to sales. EPA is a gateway to sales. Kuwait is a gateway to a gateway to sales. >>

      I agree.

    • I don't see how MicroPhage can possibly succeed. With no one on the board related to the CEO how can they be trusted? They don't even have a diver or a journalist. They don't even have the pair of law professors or better to open.

      They have a bunch of financial and health care people. What can they do?

    • Abig wrote<<Lockshed

      Great post! I would just like to add that their patents state that the kits can be used for antibiotic sensitivity. I would have to say it make no sense to me why they would use the kits to identify the bacteria and then use a petri dish to identify the proper antibiotic.
      Its like taking your car to the store and parking half way there and walking the rest of the way.>>>



      I doubt you read my post since you like to ignore reason. But if we had a trial that was doing what you want wouldn't it read more like this one below ? Read the first paragraph and then compare it with the one we have listed on our website and you will see something different ! Don't get me wrong I hope that is what they are doing over at TMC ! I just don't see any evidence of it.



      http://www.businesswire.com/news/home/20090820005851/en/MicroPhage-Opens-Pivotal-FDA-Study-Bacterial-Identification

    • Lockshed

      Great post! I would just like to add that their patents state that the kits can be used for antibiotic sensitivity. I would have to say it make no sense to me why they would use the kits to identify the bacteria and then use a petri dish to identify the proper antibiotic.
      Its like taking your car to the store and parking half way there and walking the rest of the way.

      Andre

    • Mojibes. Good thought provoking post. As for the cash situation, I am just echoing what was said via an operations update. In this case, I chose not to do the math because I don't have all the information but my point was the poster left out information that was readily available and inserted his own opinion of the cash flow situation.

      It is public information that the cost of the study (TMC's) was being funded by them.

      Also, if you read the TMC release, it says:

      A more rapid test could transform this practice, allowing us to cut down on the indiscriminate use of antibiotics, which saves money and avoids any potential adverse reactions that patients may have to them.”


      You might have to infer some things here, but the method NanoLogix uses utilizes Agar.

      http://www.rapidmicrobiology.com/test-methods/Antibiotic-Sensitivity-Testing.php

      Agar is one of the mediums/methods to determine antibiotic sensitivity. So my conclusion is if you can detect the microbial you can test AST. If you can detect the microbial 4 to 6 times faster than traditional methods, you should be able to get the antibiotic sensitivity 4-6 times faster than traditional methods.

      Also, have you considered different strains of GBS?

      http://www.ncbi.nlm.nih.gov/pubmed/8479818


      """To seek new, less expensive possibilities
      A fast cross reference.
      Spend federal grant money""""

      Your three guess above of the usage of the NanoLogix kits.

      The TMC article says nothing about your first guess. Nothing about your second guess, and nothing about your third guess. It does say if a patient in labor comes to the emergency room and you don't know if she has GBS, a faster test can help indiscriminate antibiotic use. We also know traditional methods take 48-72 hours (I am assuming with AST). Therefore, if NanoLogix's test can do it in single digit hours, there is a huge benefit. Remember, the window when a pregnant woman is tested is late term pregnancy and she may be in labor before the results come back, traditionally speaking.

    • View More Messages
 
NNLX
0.10+0.01(+11.11%)Aug 22 2:04 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.